Moxonidine in combined therapy of essential arterial hypertension patients with chronic obstructive pulmonary disease
Aim. To study moxonidine and calcium antagonist (amlodipine) effectiveness in essential arterial hypertension (EAH) treatment among patients with chronic obstructive pulmonary disease (COPD), and therapy effects on concomitant dyslipidemia. Material and methods. In total, 30 patients with EAH and St...
Main Authors: | N. R. Paleev, E. G. Shuganov, N. A. Raspopina, N. V. Vilchinskaja |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2006-08-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1228 |
Similar Items
-
Evaluation of the antihypertensive efficacy and safety of moxonidine in the treatment of uncomplicated hypertensive crisis
by: S N Tereshchenko, et al.
Published: (2013-03-01) -
ADDITIONAL BENEFITS OF ANTIHYPERTENSIVE MOXONIDINE THERAPY IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION
by: E. N. Dudinskaya, et al.
Published: (2014-02-01) -
Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01) -
Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01) -
An imidazoline receptor agonist, moxonidine, in optimization of arterial hypertension treatment among postmenopausal women
by: A. B. Bakhshaliev, et al.
Published: (2006-02-01)